國立虎尾科技大學 |

Hypoxia and cancer metastasis

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Hypoxia and cancer metastasis/ edited by Daniele M. Gilkes.
其他作者:	Gilkes, Daniele M.
出版者:	Cham :Springer International Publishing : : 2019.,
面頁冊數:	viii, 160 p. :ill., digital ; : 24 cm.;
Contained By:	Springer eBooks
標題:	Cancer. -
電子資源:	https://doi.org/10.1007/978-3-030-12734-3
ISBN:	9783030127343

Hypoxia and cancer metastasis
Hypoxia and cancer metastasis[electronic resource] /edited by Daniele M. Gilkes. - Cham :Springer International Publishing :2019. - viii, 160 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology,v.11360065-2598 ;. - Advances in experimental medicine and biology ;780..

Preface -- Hypoxia mediates tumor malignancy -- Clinical methods for quanitifying hypoxia in human tumors -- Hypoxia-induced phenotypes that mediate tumor heterogeneity -- Hypoxia and the tumors secretome -- Hypoxic signaling in angiogenesis and lymphangiogenesis -- Hypoxia induced metabolic reprogramming in cancer metastasis -- The metastatic niche and hypoxia -- Hypoxia and immune suppression -- Hypoxia-induced resistance to cancer therapy -- Therapeutic stratagies to target the hypoxic microenvironment -- Index.

The present book is an attempt to provide a detailed review of studies that clarify our current understanding of the role of hypoxia in the progression of primary cancer to metastatic disease. It will enable researchers to discover the critical cellular changes that occur under hypoxic conditions and play a role in metastatic dissemination, from the activation of hypoxia-inducible factors, HIF-1 and HIF-2, to the transcriptional profile changes that occur in cancer cells and promote cancer cell survival under detrimental conditions. Readers will discover the methods and challenges involved in imaging and quantifying the degree of hypoxia in a primary tumor. We will provide an understanding of the hypoxia-induced phenotypes that influence heterogeneity, alter the secretome and tumor microenvironment, modify cellular metabolism, and promote immune suppression and resistance to chemotherapy. Finally, we will uncover the therapeutic strategies that are being devised to target the hypoxic microenvironment in the hopes of preventing metastasis and improving the efficacy of standard-of-care cancer treatments. This work is an up to date source of information on the challenges and complexity of the hypoxic tumor microenvironment. Basic and translational scientists, post-doctoral fellows, graduate students, and those interested in how tumors metastasize will find this book a reference that details how hypoxia influences metastatic disease.

ISBN: 9783030127343

Standard No.: 10.1007/978-3-030-12734-3doiSubjects--Topical Terms:

581034
Cancer.

LC Class. No.: RA645.C3 / H96 2019

Dewey Class. No.: 614.5999

Hypoxia and cancer metastasis
LDR:03020nam a2200337 a 4500 001 940953
003 DE-He213
005 20190614152322.0
006 m d
007 cr nn 008maaau
008 200417s2019 gw s 0 eng d
020 $a 9783030127343 $q (electronic bk.)
020 $a 9783030127336 $q (paper)
024 7 $a 10.1007/978-3-030-12734-3 $2 doi
035 $a 978-3-030-12734-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RA645.C3 $b H96 2019
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 614.5999 $2 23
090 $a RA645.C3 $b H998 2019
245 0 0 $a Hypoxia and cancer metastasis $h [electronic resource] / $c edited by Daniele M. Gilkes.
260 $a Cham : $c 2019. $b Springer International Publishing : $b Imprint: Springer,
300 $a viii, 160 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology, $x 0065-2598 ; $v v.1136
505 0 $a Preface -- Hypoxia mediates tumor malignancy -- Clinical methods for quanitifying hypoxia in human tumors -- Hypoxia-induced phenotypes that mediate tumor heterogeneity -- Hypoxia and the tumors secretome -- Hypoxic signaling in angiogenesis and lymphangiogenesis -- Hypoxia induced metabolic reprogramming in cancer metastasis -- The metastatic niche and hypoxia -- Hypoxia and immune suppression -- Hypoxia-induced resistance to cancer therapy -- Therapeutic stratagies to target the hypoxic microenvironment -- Index.
520 $a The present book is an attempt to provide a detailed review of studies that clarify our current understanding of the role of hypoxia in the progression of primary cancer to metastatic disease. It will enable researchers to discover the critical cellular changes that occur under hypoxic conditions and play a role in metastatic dissemination, from the activation of hypoxia-inducible factors, HIF-1 and HIF-2, to the transcriptional profile changes that occur in cancer cells and promote cancer cell survival under detrimental conditions. Readers will discover the methods and challenges involved in imaging and quantifying the degree of hypoxia in a primary tumor. We will provide an understanding of the hypoxia-induced phenotypes that influence heterogeneity, alter the secretome and tumor microenvironment, modify cellular metabolism, and promote immune suppression and resistance to chemotherapy. Finally, we will uncover the therapeutic strategies that are being devised to target the hypoxic microenvironment in the hopes of preventing metastasis and improving the efficacy of standard-of-care cancer treatments. This work is an up to date source of information on the challenges and complexity of the hypoxic tumor microenvironment. Basic and translational scientists, post-doctoral fellows, graduate students, and those interested in how tumors metastasize will find this book a reference that details how hypoxia influences metastatic disease.
650 0 $a Cancer. $3 581034
650 0 $a Anoxemia. $3 884996
650 0 $a Oxygen in the body. $3 700689
650 1 4 $a Cancer Research. $3 668358
650 2 4 $a Human Genetics. $3 593893
650 2 4 $a Molecular Medicine. $3 668353
650 2 4 $a Cell Biology. $3 593889
700 1 $a Gilkes, Daniele M. $3 1227935
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
830 0 $a Advances in experimental medicine and biology ; $v 780. $3 881230
856 4 0 $u https://doi.org/10.1007/978-3-030-12734-3
950 $a Biomedical and Life Sciences (Springer-11642)